These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34338228)

  • 1. Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype.
    Lecce L; Xu Y; V'Gangula B; Chandel N; Pothula V; Caudrillier A; Santini MP; d'Escamard V; Ceholski DK; Gorski PA; Ma L; Koplev S; Bjørklund MM; Björkegren JL; Boehm M; Bentzon JF; Fuster V; Kim HW; Weintraub NL; Baker AH; Bernstein E; Kovacic JC
    J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34338228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.
    Asare Y; Campbell-James TA; Bokov Y; Yu LL; Prestel M; El Bounkari O; Roth S; Megens RTA; Straub T; Thomas K; Yan G; Schneider M; Ziesch N; Tiedt S; Silvestre-Roig C; Braster Q; Huang Y; Schneider M; Malik R; Haffner C; Liesz A; Soehnlein O; Bernhagen J; Dichgans M
    Circ Res; 2020 Aug; 127(6):811-823. PubMed ID: 32546048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis.
    Chen L; Shang C; Wang B; Wang G; Jin Z; Yao F; Yue Z; Bai L; Wang R; Zhao S; Liu E; Wang W
    Biochem Pharmacol; 2021 Oct; 192():114716. PubMed ID: 34339713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of miR-122 reduced atherosclerotic lesion formation by regulating NPAS3-mediated endothelial to mesenchymal transition.
    Wu X; Du X; Yang Y; Liu X; Liu X; Zhang N; Li Y; Jiang X; Jiang Y; Yang Z
    Life Sci; 2021 Jan; 265():118816. PubMed ID: 33278397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function.
    Helmke A; Casper J; Nordlohne J; David S; Haller H; Zeisberg EM; von Vietinghoff S
    FASEB J; 2019 Feb; 33(2):2278-2289. PubMed ID: 30260706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD163
    Mori M; Sakamoto A; Kawakami R; Guo L; Slenders L; Mosquera JV; Ghosh SKB; Wesseling M; Shiraki T; Bellissard A; Shah P; Weinkauf CC; Konishi T; Sato Y; Cornelissen A; Kawai K; Jinnouchi H; Xu W; Vozenilek AE; Williams D; Tanaka T; Sekimoto T; Kelly MC; Fernandez R; Grogan A; Coslet AJ; Fedotova A; Kurse A; Mokry M; Romero ME; Kolodgie FD; Pasterkamp G; Miller CL; Virmani R; Finn AV
    Circ Res; 2024 Jul; 135(2):e4-e23. PubMed ID: 38860377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1.
    Azghandi S; Prell C; van der Laan SW; Schneider M; Malik R; Berer K; Gerdes N; Pasterkamp G; Weber C; Haffner C; Dichgans M
    Stroke; 2015 Jan; 46(1):197-202. PubMed ID: 25388417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC9 Inhibition as a Novel Treatment for Stroke.
    Markus HS
    Stroke; 2023 Dec; 54(12):3182-3189. PubMed ID: 37942644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells.
    Kaluza D; Kroll J; Gesierich S; Manavski Y; Boeckel JN; Doebele C; Zelent A; Rössig L; Zeiher AM; Augustin HG; Urbich C; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):533-43. PubMed ID: 23288173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-to-Mesenchymal Transition: A Potential Mechanism for Atherosclerosis Plaque Progression and Destabilization.
    Li A; Peng W; Xia X; Li R; Wang Y; Wei D
    DNA Cell Biol; 2017 Nov; 36(11):883-891. PubMed ID: 28920704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability.
    Tang H; Zhu M; Zhao G; Fu W; Shi Z; Ding Y; Tang X; Guo D
    Atherosclerosis; 2018 Aug; 275():58-67. PubMed ID: 29860109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis.
    Qin W; Zhang L; Li Z; Xiao D; Zhang Y; Zhang H; Mokembo JN; Monayo SM; Jha NK; Kopylov P; Shchekochikhin D; Zhang Y
    Theranostics; 2020; 10(12):5276-5289. PubMed ID: 32373212
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability.
    Evrard SM; Lecce L; Michelis KC; Nomura-Kitabayashi A; Pandey G; Purushothaman KR; d'Escamard V; Li JR; Hadri L; Fujitani K; Moreno PR; Benard L; Rimmele P; Cohain A; Mecham B; Randolph GJ; Nabel EG; Hajjar R; Fuster V; Boehm M; Kovacic JC
    Nat Commun; 2016 Jun; 7():11853. PubMed ID: 27340017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition.
    Cai Y; Zhou Y; Yang Q; Xu J; Da Q; Ma Q; Zhao D; Lu T; Kim HW; Fulton D; Jiang X; Weintraub NL; Dong K; Xu S; Hong M; Liu Z; Huo Y
    Pharmacol Res; 2024 May; 203():107156. PubMed ID: 38522762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine N-oxide promotes PERK-mediated endothelial-mesenchymal transition and apoptosis thereby aggravates atherosclerosis.
    Bingyu W; Jun Q; Bingyang L; Xi Y; Jianqing Z; Jiangfang L
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113209. PubMed ID: 39340998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress.
    Moonen JR; Lee ES; Schmidt M; Maleszewska M; Koerts JA; Brouwer LA; van Kooten TG; van Luyn MJ; Zeebregts CJ; Krenning G; Harmsen MC
    Cardiovasc Res; 2015 Dec; 108(3):377-86. PubMed ID: 26084310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial-mesenchymal transition in atherosclerosis.
    Souilhol C; Harmsen MC; Evans PC; Krenning G
    Cardiovasc Res; 2018 Mar; 114(4):565-577. PubMed ID: 29309526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMT.
    Dong M; Zhang Y; Chen M; Tan Y; Min J; He X; Liu F; Gu J; Jiang H; Zheng L; Chen J; Yin Q; Li X; Chen X; Shao Y; Ji Y; Chen H
    Acta Pharm Sin B; 2024 Jul; 14(7):3027-3048. PubMed ID: 39027248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype.
    Malhotra R; Mauer AC; Lino Cardenas CL; Guo X; Yao J; Zhang X; Wunderer F; Smith AV; Wong Q; Pechlivanis S; Hwang SJ; Wang J; Lu L; Nicholson CJ; Shelton G; Buswell MD; Barnes HJ; Sigurslid HH; Slocum C; Rourke CO; Rhee DK; Bagchi A; Nigwekar SU; Buys ES; Campbell CY; Harris T; Budoff M; Criqui MH; Rotter JI; Johnson AD; Song C; Franceschini N; Debette S; Hoffmann U; Kälsch H; Nöthen MM; Sigurdsson S; Freedman BI; Bowden DW; Jöckel KH; Moebus S; Erbel R; Feitosa MF; Gudnason V; Thanassoulis G; Zapol WM; Lindsay ME; Bloch DB; Post WS; O'Donnell CJ
    Nat Genet; 2019 Nov; 51(11):1580-1587. PubMed ID: 31659325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EndMT: Potential Target of H
    Liu HT; Zhou ZX; Ren Z; Yang S; Liu LS; Wang Z; Wei DH; Ma XF; Ma Y; Jiang ZS
    Curr Med Chem; 2021; 28(18):3666-3680. PubMed ID: 33200693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.